Global CME Partnerships: What Works? Why? And in What Context?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27584079)

Published in J Contin Educ Health Prof on January 01, 2016

Authors

Abi Sriharan1, Janet Harris, Dave Davis, Mike Clarke

Author Affiliations

1: Dr. Sriharan: Assistant Dean, Continuing Professional Development, Northeast Ohio Medical University, Rootstown, OH. Dr. Harris: Professor, Section of Public Health, School of Health and Related Research, University of Sheffield, Sheffield, UK. Dr. Davis: Professor Emeritus, University of Toronto,Toronto, Canada. Dr. Clarke: Professor, Center for Public Health, Queen's University Belfast, Belfast, Northern Ireland.

Articles by these authors

(truncated to the top 100)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet (2002) 20.89

Increasing response rates to postal questionnaires: systematic review. BMJ (2002) 19.50

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet (2005) 10.00

Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39

Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2009) 7.07

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85

Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records. Stat Med (2002) 5.35

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ (2004) 4.50

Need for expertise based randomised controlled trials. BMJ (2005) 4.34

CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20

An international registry of systematic-review protocols. Lancet (2010) 3.12

Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07

Can we systematically review studies that evaluate complex interventions? PLoS Med (2009) 3.04

Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet (2010) 2.96

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev (2012) 2.86

How many Cochrane reviews are needed to cover existing evidence on the effects of health care interventions? ACP J Club (2003) 2.81

Practitioner and organizational barriers to evidence-based practice of physical therapists for people with stroke. Phys Ther (2007) 2.63

Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol (2011) 2.59

Is evidence-based medicine relevant to the developing world? PLoS Med (2005) 2.50

How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician (2003) 2.42

How to formulate research recommendations. BMJ (2006) 2.38

Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol (2010) 2.16

Evaluating maternity care: a core set of outcome measures. Birth (2007) 2.03

Balancing benefits and harms in health care. BMJ (2003) 2.01

Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council. Int J Epidemiol (2004) 1.95

Evaluating the teaching of evidence based medicine: conceptual framework. BMJ (2004) 1.94

Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int (2003) 1.86

The origins, evolution, and future of The Cochrane Database of Systematic Reviews. Int J Technol Assess Health Care (2009) 1.84

PROSPERO at one year: an evaluation of its utility. Syst Rev (2013) 1.83

Comparison of midwife-led and consultant-led care of healthy women at low risk of childbirth complications in the Republic of Ireland: a randomised trial. BMC Pregnancy Childbirth (2011) 1.80

Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J Clin Epidemiol (2013) 1.73

Can a core outcome set improve the quality of systematic reviews?--a survey of the Co-ordinating Editors of Cochrane Review Groups. Trials (2013) 1.69

Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ (2005) 1.68

The COMET (Core Outcome Measures in Effectiveness Trials) Initiative: Its Role in Improving Cochrane Reviews. Cochrane Database Syst Rev (2012) 1.68

Establishing a minimum dataset for prospective registration of systematic reviews: an international consultation. PLoS One (2011) 1.66

The COMET Initiative database: progress and activities from 2011 to 2013. Trials (2014) 1.64

Sharing evidence on humanitarian relief. BMJ (2005) 1.56

STROBE: new standards for reporting observational epidemiology, a chance to improve. Int J Epidemiol (2007) 1.54

Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ (2005) 1.52

How many do I need? Basic principles of sample size estimation. J Adv Nurs (2004) 1.50

Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials (2013) 1.47

Sixteen-year single-surgeon experience with coil embolization for ruptured intracranial aneurysms: recurrence rates and incidence of late rebleeding. Clinical article. J Neurosurg (2010) 1.46

The typical Cochrane review. How many trials? How many participants? Int J Technol Assess Health Care (2002) 1.45

How important is the size of a reprint order? Int J Technol Assess Health Care (2003) 1.40

Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension. J Contin Educ Health Prof (2002) 1.37

Barriers to the uptake of evidence from systematic reviews and meta-analyses: a systematic review of decision makers' perceptions. BMJ Open (2012) 1.33

How useful are Cochrane reviews in identifying research needs? J Health Serv Res Policy (2007) 1.33

How the Cochrane collaboration is responding to the Asian tsunami. PLoS Med (2005) 1.30

A guide to the Canadian Medical Association handbook on clinical practice guidelines. CMAJ (2007) 1.26

The trials methodological research agenda: results from a priority setting exercise. Trials (2014) 1.24

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis (2007) 1.24

Is evidence-based medicine relevant to the developing world?: Systematic reviews have yet to achieve their potential as a resource for practitioners in developing countries. Evid Based Complement Alternat Med (2005) 1.19

Interaction of St John's wort with conventional drugs: systematic review of clinical trials. BMJ (2004) 1.17

The use of systematic reviews and other research evidence in disasters and related areas: preliminary report of a needs assessment survey. PLoS Curr (2013) 1.15

The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials. Account Res (2004) 1.14

Attention should be given to multiplicity issues in systematic reviews. J Clin Epidemiol (2008) 1.13

Optimism bias leads to inconclusive results-an empirical study. J Clin Epidemiol (2010) 1.12

Fostering knowledge exchange between researchers and decision-makers: exploring the effectiveness of a mixed-methods approach. Health Policy (2007) 1.12

Reporting of adverse events in systematic reviews can be improved: survey results. J Clin Epidemiol (2008) 1.11

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction (2010) 1.11

Visualization of evidence-based medicine domain knowledge: production and citation of Cochrane systematic reviews. J Evid Based Med (2013) 1.11

The contingencies of organizational learning in long-term care: factors that affect innovation adoption. Health Care Manage Rev (2005) 1.07

Reporting of trials presented in conference abstracts needs to be improved. J Clin Epidemiol (2006) 1.05

How outcomes are defined in clinical trials of mechanically ventilated adults and children. Am J Respir Crit Care Med (2014) 1.05

Towards a methodology for cluster searching to provide conceptual and contextual "richness" for systematic reviews of complex interventions: case study (CLUSTER). BMC Med Res Methodol (2013) 1.04

Developing complex interventions for nursing: a critical review of key guidelines. J Clin Nurs (2013) 1.03

A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. Eur J Obstet Gynecol Reprod Biol (2008) 1.03

Abstracts presented at the American Society of Clinical Oncology conference: how completely are trials reported? Clin Trials (2005) 1.02

SWAT 1: what effects do site visits by the principal investigator have on recruitment in a multicentre randomized trial? J Evid Based Med (2013) 1.02

Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews. J Health Serv Res Policy (2013) 1.00

The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. BMC Med Res Methodol (2013) 0.99

A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol (2007) 0.98

The sensitivity and precision of search terms in Phases I, II and III of the Cochrane Highly Sensitive Search Strategy for identifying reports of randomized trials in medline in a specific area of health care--HIV/AIDS prevention and treatment interventions. Health Info Libr J (2007) 0.98

The role of collegial interaction in continuing professional development. J Contin Educ Health Prof (2007) 0.97

Celebrating methodological challenges and changes: reflecting on the emergence and importance of the role of qualitative evidence in Cochrane reviews. Syst Rev (2013) 0.97

The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada. Implement Sci (2007) 0.97

Enhancing continuity of information: essential components of a referral document. Can Fam Physician (2008) 0.96

Making evidence more wanted: a systematic review of facilitators to enhance the uptake of evidence from systematic reviews and meta-analyses. Int J Evid Based Healthc (2012) 0.94

Why don't we have all the evidence on oseltamivir? BMJ (2009) 0.93

Spanning the know-do gap: understanding knowledge application and capacity in long-term care homes. Soc Sci Med (2010) 0.93

Challenges in multidisciplinary cancer care among general surgeons in Canada. BMC Med Inform Decis Mak (2008) 0.93

Number and size of randomized trials reported in general health care journals from 1948 to 1997. Int J Epidemiol (2002) 0.92

How common are myeloproliferative neoplasms? A systematic review and meta-analysis. Am J Hematol (2014) 0.92

Methodology of neuropsychological research in multicentre randomized clinical trials: a model derived from the International Subarachnoid Aneurysm Trial. Clin Trials (2004) 0.92

DEALING WITH DISASTER DATABASES - WHAT CAN WE LEARN FROM HEALTH AND SYSTEMATIC REVIEWS?: Application in practice. PLoS Curr (2011) 0.92

Natural health product-drug interactions: a systematic review of clinical trials. Ther Drug Monit (2005) 0.91

Living with advanced cancer and short life expectancy: patients' experiences with managing medication. J Palliat Care (2009) 0.91

Home based computer-assisted upper limb exercise for young children with cerebral palsy: a feasibility study investigating impact on motor control and functional outcome. J Rehabil Med (2011) 0.91

The use of the opinion leader in continuing medical education. Med Teach (2003) 0.90

The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can J Public Health (2008) 0.90

Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics (2012) 0.89

A call for systematic reviews. J Gen Intern Med (2004) 0.87

Submaximal exercise testing predicts perioperative hospitalization after aortic aneurysm repair. J Vasc Surg (2012) 0.86

Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Eur J Clin Pharmacol (2005) 0.86

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials. BMC Med (2005) 0.86